Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Debt Ratio (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 4 years of Debt Ratio data on record, last reported at 0.3 in Q3 2025.

  • For Q3 2025, Debt Ratio changed N/A year-over-year to 0.3; the TTM value through Sep 2025 reached 0.3, changed N/A, while the annual FY2024 figure was 0.24, N/A changed from the prior year.
  • Debt Ratio reached 0.3 in Q3 2025 per VRCA's latest filing, down from 0.32 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.67 in Q2 2022 and bottomed at 0.24 in Q4 2024.
  • Average Debt Ratio over 4 years is 0.42, with a median of 0.4 recorded in 2021.
  • The widest YoY moves for Debt Ratio: up 61.01% in 2022, down 55.88% in 2022.
  • A 4-year view of Debt Ratio shows it stood at 0.52 in 2021, then grew by 28.13% to 0.67 in 2022, then plummeted by 64.15% to 0.24 in 2024, then rose by 27.46% to 0.3 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.3 in Q3 2025, 0.32 in Q2 2025, and 0.3 in Q1 2025.